Varex Imaging Co. (NASDAQ:VREX) Shares Purchased by Isthmus Partners LLC

Isthmus Partners LLC increased its position in shares of Varex Imaging Co. (NASDAQ:VREXFree Report) by 1.2% in the second quarter, HoldingsChannel.com reports. The firm owned 172,022 shares of the company’s stock after acquiring an additional 2,058 shares during the quarter. Varex Imaging comprises 1.0% of Isthmus Partners LLC’s holdings, making the stock its 28th largest position. Isthmus Partners LLC’s holdings in Varex Imaging were worth $2,534,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of VREX. LSV Asset Management grew its stake in shares of Varex Imaging by 17.9% during the fourth quarter. LSV Asset Management now owns 45,500 shares of the company’s stock worth $933,000 after purchasing an additional 6,900 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Varex Imaging by 5.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 529,243 shares of the company’s stock valued at $10,849,000 after acquiring an additional 26,411 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in Varex Imaging by 6.6% in the fourth quarter. BNP Paribas Financial Markets now owns 36,845 shares of the company’s stock valued at $755,000 after acquiring an additional 2,274 shares in the last quarter. Jump Financial LLC acquired a new position in Varex Imaging in the fourth quarter valued at $214,000. Finally, Dimensional Fund Advisors LP boosted its stake in Varex Imaging by 6.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,519,686 shares of the company’s stock valued at $51,654,000 after acquiring an additional 145,968 shares in the last quarter.

Varex Imaging Stock Performance

Shares of VREX traded down $0.42 during mid-day trading on Friday, hitting $11.55. 298,747 shares of the company’s stock were exchanged, compared to its average volume of 410,338. Varex Imaging Co. has a fifty-two week low of $10.72 and a fifty-two week high of $21.50. The firm has a market capitalization of $472.40 million, a P/E ratio of 12.98 and a beta of 0.56. The business’s 50 day moving average is $13.21 and its two-hundred day moving average is $15.29. The company has a current ratio of 3.34, a quick ratio of 1.89 and a debt-to-equity ratio of 0.67.

Varex Imaging (NASDAQ:VREXGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.05). The firm had revenue of $209.00 million during the quarter, compared to analyst estimates of $209.50 million. Varex Imaging had a net margin of 4.11% and a return on equity of 6.11%. Varex Imaging’s revenue for the quarter was down 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.37 EPS. On average, equities analysts expect that Varex Imaging Co. will post 0.46 earnings per share for the current year.

Insider Activity at Varex Imaging

In related news, SVP Kimberley E. Honeysett sold 2,578 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $12.53, for a total value of $32,302.34. Following the completion of the sale, the senior vice president now owns 275 shares in the company, valued at $3,445.75. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Varex Imaging news, SVP Kimberley E. Honeysett sold 2,578 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $12.53, for a total value of $32,302.34. Following the completion of the transaction, the senior vice president now directly owns 275 shares of the company’s stock, valued at $3,445.75. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Shubham Maheshwari bought 9,007 shares of the company’s stock in a transaction on Friday, August 9th. The stock was bought at an average cost of $10.98 per share, with a total value of $98,896.86. Following the completion of the acquisition, the chief financial officer now owns 46,063 shares of the company’s stock, valued at approximately $505,771.74. The disclosure for this purchase can be found here. 5.20% of the stock is owned by insiders.

Analysts Set New Price Targets

Separately, B. Riley assumed coverage on shares of Varex Imaging in a research note on Friday, August 23rd. They issued a “buy” rating and a $21.00 price objective for the company.

View Our Latest Stock Analysis on VREX

Varex Imaging Company Profile

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Read More

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREXFree Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.